Concepedia

Daniel K. Gehlhaar

DK

Statistics

Publications

18

Citations

2.3K

H-Index

15

Active since

1995

Affiliations

Pfizer (United States)(Current)

Agouron Institute

Torrey Pines Institute For Molecular Studies

Natural Selection (United States)

Daniel K. Gehlhaar is an author at Pfizer (United States) specializing in structural biology, ligand binding, and computational chemistry.

ORCID

Publications per year

1995–2012

18

Publications

18

Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming

Daniel K. Gehlhaar, Gennady M. Verkhivker, Paul A. Rejto et al. · Chemistry & Biology · 1995 · 685 citations · Full text

, , +17

Rapid automated molecular replacement by evolutionary search

Charles R. Kissinger, Daniel K. Gehlhaar, David B. Fogel · Acta Crystallographica Section D Biological Crystallography · 1999 · 580 citations

, , +7

Deciphering common failures in molecular docking of ligand-protein complexes

Gennady M. Verkhivker, Djamal Bouzida, Daniel K. Gehlhaar et al. · Journal of Computer-Aided Molecular Design · 2000 · 242 citations

, , +16

Redesigning and characterizing the substrate specificity and activity of Vibrio fluvialis aminotransferase for the synthesis of imagabalin

Katarina S. Midelfort, R. Pravin Kumar, Seungil Han et al. · Protein Engineering Design and Selection · 2012 · 135 citations · Full text

, , +17

De Novo Design of Enzyme Inhibitors by Monte Carlo Ligand Generation

Daniel K. Gehlhaar, Karl E. Moerder, Dominic A. Zichi et al. · Journal of Medicinal Chemistry · 1995 · 126 citations

, , +12

1–5 of 18